HCPCS Code Descriptor:
Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg
FULVESTRANT 505(b)(2) Pathway
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
FULVESTRANT is an Oncology drug manufactured by Teva and administered via the Intramuscular route of administration. The J Code: J9393 is aligned to the drug FULVESTRANT.
Fulvestrant is an estrogen receptor antagonist which binds to the receptor in breast cancer cells for the hormone estrogen. After binding to these breast cancer cells, it eventually degrades them. This medication is administered via injection into the muscle. Patient assistance can be found through the Fresenius Kabi patient support site.